By continuing to browse the site you are agreeing to our use of cookies and similar tracking technologies described in our privacy policy.

Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Patients Co-infected with HCV and HIV-1: The Phase 3 ASTRAL-5 Study Abstract PS104

Journal

International Liver Congress 2016. April 13-17.

Year of Publication

2016

Authors

Type of Article

Conference Paper